Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection

Infection and Immunity

Volumn 77, Issue 2, 2009, Pages 632-641

  Alamuri, Praveen ^a   Eaton, Kathryn A ^a   Himpsl, Stephanie D ^a   Smit, Sara N ^a   Mobley, Harry L T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; CYTOTOXIN; HEMOLYSIN; HPMA HEMOLYSIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEUS TOXIC AGGLUTININ; PROTEUS TOXIC AGGLUTININ ALPHA CHOLERA TOXIN CONJUGATE; PROTEUS TOXIC AGGLUTININ CHOLERA TOXIN CONJUGATE; UNCLASSIFIED DRUG; AGGLUTININ; BACTERIAL PROTEIN; BACTERIAL VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL GENE; CONTROLLED STUDY; CYSTITIS; CYTOTOXICITY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GENE INACTIVATION; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; HPMA GENE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IN VIVO STUDY; INTERSTITIAL NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEUS INFECTION; PROTEUS MIRABILIS; PTA GENE; SPLEEN; TREATMENT RESPONSE; URINARY TRACT INFECTION; VACCINATION; WILD TYPE; ANIMAL; BLADDER; CBA MOUSE; IMMUNOLOGY; KIDNEY; MICROBIOLOGY; PATHOLOGY;

AGGLUTININS; ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; FEMALE; HEMOLYSIN PROTEINS; KIDNEY; MICE; MICE, INBRED CBA; PROTEUS INFECTIONS; PROTEUS MIRABILIS; SPLEEN; URINARY BLADDER; URINARY TRACT INFECTIONS; VACCINATION;

EID: 60549099566     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01050-08     Document Type: Article

References (40)

1. Alamuri, P., and H. L. Mobley. 2008. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin. Mol. Microbiol. 68:997-1017.
2. Allison, C., H. C. Lai, and C. Hughes. 1992. Co-ordinate expression of virulence genes during swarm-cell differentiation and population migration of Proteus mirabilis. Mol. Microbiol. 6:1583-1591.
3. Bahrani, F. K., D. E. Johnson, D. Robbins, and H. L. Mobley. 1991. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Infect. lmmun. 59:3574-3580.
4. Braun, V., and T, Focareta. 1991. Pore-forming bacterial protein hemolysins (cytolysins). Crit. Rev. Microbiol. 18:115-158.
5. Cover, T. L., and S. R. Blanke. 2005. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol. 3:320-332.
6. Fraser, G. M., L. Claret", R. Fnrness, S. Gupta, and C. Hughes. 2002. Swarming-coupled expression of the Proteus mirabilis hpmBA haemolysin operon. Microbiology 148:2191-2201.
7. Grdic, D., L. Ekman, K. Schon, K. Lindgren, J. Mattsson, K. E. Magnusson, P. Ricciardi-Castagnoli, and N. Lycke. 2005. Splenic marginal zone dendritic cells mediate the cholera toxin adjuvant effect: dependence on the ADP-ribosyltransferase activity of the holotoxin. J. Immunol. 175:5192-5202.
8. Griffith, D. P., D, M, Musher, and C. Itin, 1976. Urease. The primary cause of infection-induced urinary stones, lnvestig. Urol. 13:346-350.
9. Hadi, H. A., K. G. Wooldridge, K. Robinson, and D. A. Ala'Aldeen. 2001. Identification and characterization of App: an immunogenic autotransporter protein of Neisseria meningitidis. Mol. Microbiol. 41:611-623.
10. Hopkins, W. J., and D. T. Uehling. 1995. Resolution time of Escherichia coli cystitis is correlated with levels of preinfection antibody to the infecting Escherichia coli strain. Urology 45:42-46.
11. Johnson, D. E., R. G. Russell, C. V. Lockatell, J. C, Zulty, J. W. Warren, and H. L. Mobley. 1993. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect. lmmun. 61:2748-2754.
12. Jones, B. D., C. V. Lockatell, D. E. Johnson, J. W. Warren, and H. L. Mobley. 1990. Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect. lmmun. 58:1120-1123.
13. Kaca, W., and A. Rozalski. 1991. Characterization of cell-bound and cell-free hemolytic activity of Proteus strains. Eur. J. Epidemiol. 7:159-165.
14. Kotelko, K., W. Kaca, A. Rozalski, and M. Deka. 1983. Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains. Acta Microbiol. Pol. 32:345-351.
15. Kwissa, M., R. R. Amara, H. L. Robinson, B. Moss, S. Alkan, A. Jabbar, F. Villinger, and B. Pulendran. 2007. Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus. J. Exp. Med. 204:2733-2746.
16. Li, W., M. H, Sofi, N. Yeh, S. Sehra, B, P. McCarthy, D. R. Patel, R. R. Brutkiewicz, M. H. Kaplan, and C. H. Chang. 2007. Thymic selection pathway regulates the effector function of CD4 T cells. J. Exp. Med. 204:2145- 2157.
17. Li, X., J. L. Erbe, C. V. Lockatell, D. E. Johnson, M. G. Jobling, R. K. Holmes, and H. L. Mobley. 2004. Use of translational fusion of the MrpH fimbrial ad he sin-binding domain with the cholera toxin A2 domain, coex- pressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis. Infect. lmmun. 72:7306-7310.
18. Li, X., C. V. Lockatell, D. E. Johnson, M. C. Lane, J. W. Warren, and H. L. Mobley. 2004. Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Infect. lmmun. 72:66-75.
19. Li, X., and H. L. Mobley. 2002. Vaccines for Proteus mirabilis in urinary tract infection. Int. J. Antimicrob. Agents 19:461-465.
20. Liu, D. F., K. W. Mason, M. Mastri, M. Pazirandeh, D. Cutter, D. L. Fink, J. W. St. Geme III, D. Zhu, and B. A. Green. 2004. The C-terminal fragment of the internal 110-kilodalton passenger domain of the Hap protein of nontypeable Haemophilus influenzae is a potential vaccine candidate. Infect, lmmun. 72:6961-6968.
21. Marr, N., D. C. Oliver, V. Laurent, J. Poolman, P. Denoel, and R. C. Fernandez. 2008. Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model. Vaccine 26:4306-4311.
22. Moayeri, N., C. M. Collins, and P. O'Hanley. 1991. Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model. Infect, lmmun. 59:3778-3786.
23. Mobley, H. L. T., and J. W. Warren. 1987. Urease-positive bacteriuria and obstruction of long-term urinary catheters J. Clin. Microbiol. 25:2216-2217.
24. Mobley, H. L., and G. R. Chippendale. 1990. Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources. J. Infect. Dis. 161:525-530.
25. Murphy, C. A., and R. Belas. 1999. Genomic rearrangements in the flagellin genes of Proteus mirabilis. Mol. Microbiol. 31:679-690.
26. Nemoy, N. J., and T. A. Staney. 1971. Surgical, bacteriological, and biochemical management of "infection stones." JAMA 215:1470-1476.
27. Nielubowicz, G. R., S. N. Smith, and H. L. Mobley. 2008. Outer membrane antigens of the uropathogen Proteus mirabilis recognized by the humoral response during experimental murine urinary tract infection. Infect, lmmun. 76:4222-4321.
28. Reed, L. J., and H. A. Muench, 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
29. Salama, N. R., G. Otto, L. Tompkins, and S. Falkow. 2001. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect, lmmun. 69:730-736.
30. Scavone, P., A. Miyoshi, A, Rial, A. Chabalgoity, P. Langella, V. Azevedo, and P. Zunino. 2007. Intranasal immunization with recombinant Lactococcuslactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonization in mice. Microbes Infect. 9:821-828.
31. Smith, Y. C., S. B. Rasmussen, K. K. Grande, R. M. Conran, and A. D. O'Brien. 2008. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect. lmmun. 76:2978-2990.
32. Swihart, K., and R. A. Welch. 1990. Cytotoxic activity of the Proteus hemolysisn HpmA. Infect. lmmun. 58:1861-1869.
33. Swihart, K. G., and R. A. Welch. 1990. The HpmA hemolysin is more common than HlyA among Proteus isolates. Infect. lmmun. 58:1853-1860.
34. Taddei, C. R., A. Fasano, A. J. Ferreira, L. R. Trabulsi, and M. B. Martinez. 2005. Secreted autotransporter toxin produced by a diffusely adhering Escherichia coli strain causes intestinal damage in animal model assays. FEMS -Microbiol. Lett. 250:263-269.
35. Warren, J. W. 1991. The catheter and urinary tract infections. Med. Clin. N. Am. 75:481-493.
36. Warren, J. W., D. Damron, J. H. Tenney, J. M. Hoopes, B. Deforge, and H. L. Muncie, Jr. 1987. Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. J. Infect. Dis. 155:1151-1158.
37. Warren, J. W., H. L. Muncie, Jr., and M. Hall-Craggs, 1988. Acute pyelonephritis associated with bacteriuria during long-term catheterization: a propspective clinicopathological study. J. Infect. Dis. 158:1341-1346.
38. Welch, R. A. 1991. Pore-forming cytolysins of gram-negative bacteria. Mol. Microbiol. 5:521-528.
39. Welch, R. A., C. Forestier, A. Lobo, S. Pellett, W. Thomas, Jr., and G. Rowe. 1992. The synthesis and function of the Escherichia coli hemolysin and related RTX exotoxins. FEMS Microbiol. Immunol. 5:29-36.
40. Zhao, H., X. Li, D. E. Johnson, I. Blomfield, and H. L. Mobley. 1997. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract. Mol. Microbiol. 23:1009-1019.